60 Recruiting Prostate Cancer Phase 1 Clinical Trials
Active phase 1 studies for prostate cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Prostate Cancer studiesPhase 1 Studies for Prostate Cancer
Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer
π University of Texas Southwestern Medical Center β Dallas, Texas
View Study & Checklist βAdaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer
π H. Lee Moffitt Cancer Center and Research Institute β Tampa, Florida
View Study & Checklist βHypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)
π Maryland Proton Treatment Center β Baltimore, Maryland
View Study & Checklist βAdoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)
π Memorial Sloan Kettering Cancer Center β New York, New York
View Study & Checklist βImaging and Genomic Biomarkers to Predict Response in Prostate Cancer
π University of Wisconsin β Madison, Wisconsin
View Study & Checklist βAndrogen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
π University of Wisconsin Carbone Cancer Center β Madison, Wisconsin
View Study & Checklist βEvaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer
π Abramson Cancer Center of the University of Pennsylvania β Philadelphia, Pennsylvania
View Study & Checklist βIntermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
π H. Lee Moffitt Cancer Center and Research Institute β Tampa, Florida
View Study & Checklist βPhase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC
π Tulane Cancer Center Clinic β New Orleans, Louisiana
View Study & Checklist βCART-PSMA-TGFΞ²RDN Cells for Castrate-Resistant Prostate Cancer
π University of Pennsylvania β Philadelphia, Pennsylvania
View Study & Checklist βIntermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer
π Odette Cancer Centre β Toronto, Ontario
View Study & Checklist βMagnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer
π University of California, San Francisco β San Francisco, California
View Study & Checklist βLuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer
π Beth Israel Deaconess Medical Center β Boston, Massachusetts
View Study & Checklist βPeriprostatic Neurolysis in Prostate Cancer
π University of Texas Southwestern Medical Center β Dallas, Texas
View Study & Checklist βHigh-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
π Thomas Jefferson University β Philadelphia, Pennsylvania
View Study & Checklist βLong Acting Neuraxial Peri-prostatic Block in Cancer
π Icahn School of Medicine at Mount Sinai β New York, New York
View Study & Checklist βA Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
π University of Michigan Rogel Cancer Center β Ann Arbor, Michigan
View Study & Checklist βCombination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
π H. Lee Moffitt Cancer Center and Research Institute β Tampa, Florida
View Study & Checklist βCombining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naΓ―ve Patients With Progressive Metastatic Castration-resistant Prostate Cancer
π Northwestern University β Evanston, Illinois
View Study & Checklist β[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer
π Juravinski β Hamilton,
View Study & Checklist βPET/MRI for the Staging of Newly Diagnosed Prostate Cancer
π Northwestern University β Chicago, Illinois
View Study & Checklist βEvaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer
π University of Minnesota Medical Center Fairview β Minneapolis, Minnesota
View Study & Checklist βA Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer
π Montefiore Medical Center - Moses Campus β The Bronx, New York
View Study & Checklist βPhase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT
π Mayo Clinic Rochester β Rochester, Minnesota
View Study & Checklist βPET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer
π University of California, San Francisco β San Francisco, California
View Study & Checklist βFractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC
π Brooklyn Methodist Hospital - New York Presbyterian β Brooklyn, New York
View Study & Checklist βThe Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting.
π Icahn School of Medicine at Mount Sinai (ISMMS) β New York, New York
View Study & Checklist βNivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
π Winship Cancer Institute, Emory University β Atlanta, Georgia
View Study & Checklist βA Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer
π Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) β Basking Ridge, New Jersey
View Study & Checklist βGenetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery
π City of Hope Medical Center β Duarte, California
View Study & Checklist βPreoperative Semaglutide Prior to Radical Prostatectomy
π Banner MD Anderson Cancer Center at Gateway β Gilbert, Arizona
View Study & Checklist βSipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer
π Washington University School of Medicine β St Louis, Missouri
View Study & Checklist βResponse With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy Delivery
π University of Texas Southwestern Medical Center β Dallas, Texas
View Study & Checklist βdMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy
π Icahn School of Medicine at Mount Sinai β New York, New York
View Study & Checklist βCOQ10 and Vitamin E for Off-Target Radiation Toxicity
π University of Nebraska Medical Center β Omaha, Nebraska
View Study & Checklist βStudy of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
π City of Hope National Medical Center β Duarte, California
View Study & Checklist βTelmisartan in Prostate Cancer
π Dartmouth Health β Lebanon, New Hampshire
View Study & Checklist βPhase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
π MD Anderson Cancer Center β Houston, Texas
View Study & Checklist βNeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
π M D Anderson Cancer Center β Houston, Texas
View Study & Checklist βAnti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
π Biogenix Molecular LLC β Miami, Florida
View Study & Checklist βStudy of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
π University of Alabama at Birmingham Hospital β Birmingham, Alabama
View Study & Checklist βEvaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
π University of California San Francisco β San Francisco, California
View Study & Checklist βA Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
π The University of Texas M. D. Anderson Cancer Center β Houston, Texas
View Study & Checklist βStudy of STM-416p Administered to Patients Undergoing Radical Prostatectomy
π Arizona Urology Specialists β Tucson, Arizona
View Study & Checklist βComparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
π University of California, San Francisco β San Francisco, California
View Study & Checklist βTwo Fraction Prostate SBRT With DIL SIB
π NYU Langone Hospital - Long Island β Mineola, New York
View Study & Checklist β64Cu-GRIP B in Patients With Advanced Malignancies
π University of California, San Francisco β San Francisco, California
View Study & Checklist βA Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
π Research Site β Orlando, Florida
View Study & Checklist βA Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
π HCA Florida Kendall Hospital β Miami, Florida
View Study & Checklist βStudy of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
π Washington University School of Medicine β St Louis, Missouri
View Study & Checklist βSafety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
π Penn State Cancer Institute β Hershey, Pennsylvania
View Study & Checklist βPhase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
π Brooklyn Methodist Hospital - New York Presbyterian β Brooklyn, New York
View Study & Checklist βBehavioral Exercise Training to Reduce Cardiovascular Disease Risk
π Richmond Veterans Affairs Medical Center β Richmond, Virginia
View Study & Checklist βImage-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
π SKCCC at Johns Hopkins β Baltimore, Maryland
View Study & Checklist βThe Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
π Memorial Sloan Kettering Cancer Center β New York, New York
View Study & Checklist βPhase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
π Dana-Farber Cancer Institute β Boston, Massachusetts
View Study & Checklist βA Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
π John Theurer Cancer Center β Hackensack, New Jersey
View Study & Checklist βA Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
π Research Site β Duarte, California
View Study & Checklist βPhotodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
π Memorial Sloan Kettering Cancer Center β New York, New York
View Study & Checklist βA Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
π M D Anderson Cancer Center β Houston, Texas
View Study & Checklist β